Core Insights - Michael Burry has liquidated nearly his entire portfolio, retaining only Estée Lauder Companies Inc. stock, which has shown significant gains following the news of Leonard Lauder's death [1][5] - Estée Lauder shares closed at $74.59, reflecting a daily increase of 10.82% [1] - Insider confidence is indicated by the purchase of over 133,000 shares in February, and a surge in call options volume by over 70% on Monday [3] Company Performance - Burry holds 200,000 shares of Estée Lauder, purchased at an average price of $66.00, representing 100% of his disclosed portfolio, with a current value of approximately $13.2 million [4] - The stock remains below its 52-week high of $113.30 but has rebounded from a low of $48.12, suggesting potential for operational recovery and brand repositioning [5] Market Sentiment - The recent stock movement indicates a positive sentiment among traders, with expectations of continued momentum in the short term [3] - Burry's concentrated investment suggests he anticipates significant upside potential in the consumer staples and luxury sectors [5]

Quantitative Primer Everything you wanted to know about quant*… Strategy *But were too afraid to ask. Our mosaic of signals… In our 16th annual edition of our quantitative primer, we include macro, sector, stock selection and asset allocation models spanning four decades of performance. These signals represent the underpinnings of our strategy outlook. In our Primer we cover the philosophy behind our models – common sense meets rigorous testing. …hide a graveyard of failed backtests Most of our analyses nev ...

A bit of a reversal Carol Massar from what we saw on Friday with the big sell off. And today it's a big buy the dip. I know.And I'm trying to figure out like how much has really changed. But having said that, I of just keep digging down. There's a lot of gainers in today's session.Semiconductors in particular, guys up almost 3%. So really some outperformance there today. I guess the optimism about perhaps Iran wants to talk to find some resolution to this.Got people more optimistic, Scarlett. But still, it ...

This is an investigation, a deep one, Ryan, just showing how actually we shouldn't really be using text SMS as a form of two factor authentication. That's right. Yeah.We we looked in depth at this issue because I think a lot of people don't realize that when you log to whether it's a banking app or whether it's Google or metal, when you receive one of these logging codes via SMS, it's not actually coming directly from the tech company or the platform that you're logging into is routed through intermediaries ...

Group 1 - The article discusses the organic growth challenges faced by Apple compared to other major companies in the industry [1] - Oliver Rodzianko is the Founder and CEO of Invictus Origin, an investment management firm focused on high-alpha strategies, launched in May 2025 [1] - Invictus Origin's flagship portfolio, the Nasdaq High-Alpha Black Swan Portfolio, aims to outperform the Nasdaq-100 while maintaining approximately 20% in cash reserves for downside protection [1] Group 2 - Oliver Rodzianko has extensive experience as a macro-focused investment analyst, specializing in sectors such as technology, semiconductors, artificial intelligence, and energy [1] - The investment process at Invictus Origin integrates U.S. market specialization with international market awareness, aiming for durable outperformance [1] - The firm is characterized by resilience, performance, and disciplined capital stewardship, supported by a family office structure for lower-volatility capital preservation [1]

What if I told you that the design of your workspace may be quietly undermining your success more than your boss or your company's strategy. Y research shows that poor design can reduce your productivity by as much as 20%. Yet we often treat it like an afterthought.Now you may be wondering if research design matters that much, why aren't we paying it much uh more attention. If workplace design really matters, why aren't CEOs and managers treating it like a strategic asset. Well, somewhere pre- pandemic, man ...

¿Quién de ustedes puede leer lo que sale acá. A ver, levante la mano. Nadie.Ya. Menos mal, porque si no hubieran echado perder el comienzo de la charla. ¿Qué pasaría si yo les digo que el sueldo a fin de mes depende de su capacidad de leer esto.¿Qué harían. Seguramente empezarían a tratar de leerlo. Se sentirían un poquitito ansiosos, nerviosos, frustrados, después de un rato desmotivados y quizás perderían el interés y quizás hasta renuncien a la pega.Bueno, esto es lo que sienten cientos de miles de niños ...

Nationally ranked stock picker for 30 years. Victory Formation and Bottom Fishing Club quant-sort pioneer.....Paul Franke is a private investor and speculator with 39 years of trading experience. Mr. Franke was Editor and Publisher of the Maverick Investor® newsletter during the 1990s, widely quoted by CNBC®, Barron’s®, the Washington Post® and Investor’s Business Daily®. Paul was consistently ranked among top investment advisors nationally for stock market and commodity macro views by Timer Digest® during ...

继去年11月西安奕材IPO申请获得科创板受理之后，近日，又一家未盈利半导体硅片企业——上海超硅半导体股份有限公司（简称"上海超硅"） 的科创板IPO申请获受理。 招股书显示，上海超硅主要从事全球半导体市场需求最大的300mm和200mm半导体硅片的研发、生产、销售，同时公司还从事包括硅片再生以及硅棒后道加工等 受托加工业务，已经发展为国际知名的半导体硅片厂商。 值得注意的是，上海超硅虽然尚未实现盈利，但经过数轮融资，其背后有上海、重庆等多家地方国资入股。同时，上海超硅预计将募资近50亿元。 | | | | | TIL: /4/U | | --- | --- | --- | --- | --- | | 序号 | 项目名称 | 实施主体 | 总投资金额 | 使用募集资 | | | | | | 金投入金额 | | 序号 | 项目名称 | 实施主体 | 总投资金额 | 使用募集资 | | --- | --- | --- | --- | --- | | | | | | 金投入金额 | | | 集成电路用 300 毫米薄层硅外延片扩产项目 | 上海超硅 | 298,081.96 | 296,534.96 | | 2 | ...

Core Insights - Penumbra, Inc. has completed enrollment in the STORM-PE clinical trial, which is a pioneering study comparing computer-assisted vacuum thrombectomy (CAVT™) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone for treating acute intermediate-high risk pulmonary embolism [1][2] - The trial enrolled 100 patients and aims to provide high-quality evidence on the effectiveness of CAVT in improving right heart function and clinical outcomes in patients with pulmonary embolism [1][2][4] - Pulmonary embolism is a significant health concern, with an estimated 900,000 symptomatic cases occurring annually in the U.S., and a mortality rate of 10-30% within one month of diagnosis [3] Company Overview - Penumbra, Inc. is recognized as the world's leading thrombectomy company, focusing on innovative technologies for medical conditions such as ischemic stroke and venous thromboembolism [6] - The company's Lightning Flash portfolio features advanced mechanical thrombectomy systems designed to remove blood clots efficiently, utilizing dual clot detection algorithms and a specialized catheter design [4][6] - Penumbra operates in over 100 countries, aiming to enhance patient outcomes and quality of life through its innovative medical solutions [6]